# AMOR

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amor-2

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.neomodulus.com
- Total disclosed funding: $23M
- Latest round: Series B (Mar 7, 2023)
- Investors on record: 7

## About

Established in 2017 and based in Nanjing, China, AMOR operates as a regenerative implantable medical device's developer that provides tissue regeneration and trauma repair solutions. The company cooperates with the University of Freiburg, Germany. It has R&D and production bases located in Suzhou, Weifang and Taicang. In December 2024, it closed a venture funding.

The company’s main business is to develop, produce, and commercialize regenerative implantable medical devices. The company’s self-developed products cover a wide range, including those based on 3D electrostatic spinning, 3D bioprinting, and chemical and physical synthesis, involving product forms such as membranes, bones, gels, agents, and (micro) balls. Its products are used in various medical fields, including dentistry, orthopedics, cardiology, ophthalmology, otolaryngology, sports medicine, and plastic surgery, aiming to solve problems in tissue regeneration, trauma repair, and functional reconstruction.

The company generates revenue by providing a variety of regenerative implantable medical devices, as well as comprehensive system solutions for tissue regeneration and trauma repair, to medical institutions and related industries.

## Funding rounds

- Series B, Mar 7, 2023 — CDH Investments, SND Ventures Group, JM Capital, 10Fund, Hyfinity Investments, Suzhou Clivia Capital Manage
- Series A, Oct 26, 2021 — SND Ventures Group, JM Capital, 10Fund, Hyfinity Investments, Westlake University Capital
- Series A, Aug 13, 2021, $23M — CDH Investments, SND Ventures Group, JM Capital, 10Fund, Hyfinity Investments
- Series A, Mar 26, 2018 — JM Capital, 10Fund, Hyfinity Investments
- Angel, Nov 21, 2017 — 10Fund

## Investors

- 10Fund (https://capitalatlas.ai/funds/10fund) — Angel, Series A, Series B
- JM Capital (https://capitalatlas.ai/funds/jm-capital) — Series A, Series B
- Hyfinity Investments (https://capitalatlas.ai/funds/hyfinity-investments) — Series A, Series B
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series A, Series B
- SND Ventures Group (https://capitalatlas.ai/funds/snd-ventures-group) — Series A, Series B
- Westlake University Capital — Series A
- Suzhou Clivia Capital Manage — Series B